| (Values in U.S. Thousands) | Aug, 2021 | May, 2021 | Feb, 2021 | Aug, 2020 | May, 2020 |
| Sales | 0 | 0 | 0 | 1 | 3 |
| Sales Growth | unch | unch | -100.00% | -60.39% | -65.33% |
| Net Income | -82 | 4,884 | -18 | -1,071 | -846 |
| Net Income Growth | -101.68% | +26,982.65% | +98.30% | -26.63% | -32.22% |
Rise Life Science Corp (RLSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
RISE Life Science Corp is engaged in developing and evolving medical and adult hemp-based formulations to create general use of health and well-being products for the emerging consumer category. It derives key revenue from the United States.
Fiscal Year End Date: 11/30